DNTH icon

Dianthus Therapeutics

98 hedge funds and large institutions have $685M invested in Dianthus Therapeutics in 2025 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 31 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
+3
Holders Change %
+3.16%
% of All Funds
1.33%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.08%
New
16
Increased
29
Reduced
31
Closed
12
Calls
$813K
Puts
$1.73M
Net Calls
-$916K
Net Calls Change
-$912K
Name Holding Trade Value Shares
Change
Shares
Change %
AI
101
Allostery Investments
Connecticut
-$545K -25,000 Closed
Swiss National Bank
102
Swiss National Bank
Switzerland
-$314K -14,400 Closed
Two Sigma Investments
103
Two Sigma Investments
New York
-$231K -10,601 Closed
A
104
AlphaQuest
New York
-$91.5K -4,197 Closed
VEA
105
Virtus ETF Advisers
New York
-$65.9K -3,025 Closed
KBC Group
106
KBC Group
Belgium
-$35K -1,593 Closed
KK
107
KLP Kapitalforvaltning
Norway
-$32.7K -1,500 Closed
RS
108
R Squared
Hong Kong
-$26.2K -1,200 Closed
LC
109
Lindbrook Capital
California
-$458 -21 Closed
CIAM
110
Caitong International Asset Management
Hong Kong
-$283 -13 Closed